Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the locoregional control in PET/CT based radiotherapy treatment planning in the treatment of esophageal cancer patients.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Maastricht Radiation Oncology
NCT06469944 · Gastroesophageal Junction, Gastroesophageal Adenocarcinoma, and more
NCT06380816 · Advanced Solid Tumours, Squamous Cell Carcinoma of Head and Neck, and more
NCT02530983 · Esophageal Neoplasms, Cancer of Esophagus, and more
NCT05875870 · Lung Neoplasm, Esophageal Neoplasms
NCT04780256 · Endoscopic Mucosal Resection, Endoscopic Submucosal Dissection, and more
Atrium Hospital
Heerlen
University Medical Center
Maastricht
St. Laurentius Hospital
Roermond
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions